Which closed-end funds own ARS Pharmaceuticals Inc?
3 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $32.3M. Security type: common equity. Country: United States. CUSIP 82835W108 · ISIN US82835W1080 · ticker SPRY.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| THQ abrdn Healthcare Opportunities Fund | Healthcare | 1.38% | $14.5M | 1,805,535 sh | $1.1B | 7.7% discount | Jun 30, 2026 |
| HQH abrdn Healthcare Investors | Healthcare | 0.93% | $12.6M | 1,574,583 sh | $1.4B | 7.5% discount | Jun 30, 2026 |
| HQL abrdn Life Sciences Investors | Healthcare | 0.76% | $5.2M | 651,538 sh | $690M | 3.5% discount | Jun 30, 2026 |
3 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Issuer-level search for “SPRY” → · Compare two funds’ portfolios →